SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-055799
Filing Date
2017-11-02
Accepted
2017-11-02 15:41:33
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477548_10q.htm 10-Q 410209
2 EXHIBIT 10.1 tv477548_ex10-1.htm EX-10.1 51114
3 EXHIBIT 31.1 tv477548_ex31-1.htm EX-31.1 12159
4 EXHIBIT 31.2 tv477548_ex31-2.htm EX-31.2 11363
5 EXHIBIT 32.1 tv477548_ex32-1.htm EX-32.1 4396
6 EXHIBIT 32.2 tv477548_ex32-2.htm EX-32.2 4282
7 GRAPHIC image_001.jpg GRAPHIC 47577
  Complete submission text file 0001144204-17-055799.txt   4129203

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT iova-20170930.xml EX-101.INS 944673
9 XBRL TAXONOMY EXTENSION SCHEMA iova-20170930.xsd EX-101.SCH 34892
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20170930_cal.xml EX-101.CAL 26728
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20170930_def.xml EX-101.DEF 265138
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20170930_lab.xml EX-101.LAB 284257
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20170930_pre.xml EX-101.PRE 299806
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 171172026
SIC: 2836 Biological Products, (No Diagnostic Substances)